Swiss (SMI) Growth Pharmaceuticals & Biotech Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Apr 15, 2026

Discover Swiss Pharmaceuticals & Biotech Growth Stocks that are on the SMI. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
PPGN	CHF 37.25	24.6%	139.1%	CHF 1.2b	CHF 36.03	3.4	58.7%	0%
KURN	CHF 25.74	8.6%	17.1%	CHF 1.0b	CHF 35.40	524.0	58.0%	n/a
TECN	CHF 141.40	4.4%	-1.7%	CHF 1.8b	CHF 166.98	2.0	51.4%	2.1%
IDIA	CHF 3.67	4.8%	226.3%	CHF 922.5m	CHF 4.50	4.2	49.6%	n/a
NWRN	CHF 16.96	13.5%	164.2%	CHF 352.9m	CHF 48.45	20.0	48.9%	n/a
COPN	CHF 101.40	13.4%	112.6%	CHF 1.6b	CHF 124.00	17.1	43.6%	1.9%
SKAN	CHF 47.65	12.2%	-23.5%	CHF 1.1b	CHF 62.50	65.8	31.0%	0.5%
BSLN	CHF 56.80	6.6%	36.2%	CHF 698.2m	CHF 89.90	17.3	26.1%	n/a
GALD	CHF 156.60	0%	99.9%	CHF 36.7b	CHF 178.40	76.7	23.4%	0.2%
MOLN	CHF 3.30	-1.2%	0.6%	CHF 123.5m	CHF 9.00	1.5	17.7%	n/a
DESN	CHF 348.50	4.8%	92.5%	CHF 4.8b	CHF 412.50	39.8	17.5%	0%
LONN	CHF 533.80	5.0%	-1.4%	CHF 37.3b	CHF 673.61	41.0	17.3%	0.9%
SDZ	CHF 67.92	4.0%	105.4%	CHF 29.4b	CHF 66.14	41.1	17.0%	1.2%
BANB	CHF 73.00	14.2%	52.5%	CHF 5.5b	CHF 78.80	36.8	15.7%	1.2%
SFZN	CHF 83.50	8.9%	-5.8%	CHF 3.7b	CHF 104.60	21.7	9.7%	0.5%
ROP	CHF 317.00	0.9%	24.6%	CHF 253.4b	CHF 351.73	19.6	8.7%	3.1%
NOVN	CHF 118.34	-2.3%	30.8%	CHF 225.8b	CHF 120.33	20.7	8.6%	3.1%
BIOV	CHF 29.00	11.5%	-17.1%	CHF 169.6m	CHF 58.26	53.4	-14.3%	n/a
ADXN	CHF 0.05	13.6%	0%	CHF 5.8m	n/a	36.8	n/a	n/a
MMTX	CHF 0.30	-9.0%	n/a	CHF 46.1m	CHF 3.41	n/a	n/a	n/a
CURN	CHF 23.40	-0.8%	134.0%	CHF 120.6m	CHF 98.10	11.2	16.4%	n/a
XLS	CHF 21.50	0%	10.5%	CHF 124.0m	n/a	4.0	n/a	n/a
SANN	CHF 18.00	8.2%	22.6%	CHF 250.7m	CHF 30.00	5.1	48.7%	n/a

Page 1 of 1